Progressive publishes new research
Updated : 07:40
Progress on all fronts
Idox's results for the year to 31 October 2021 were released this morning. The company has delivered three things during the year: material progress on all financial metrics, a major refocus through both acquisitions and disposals, and a number of clear steps forward in terms of organisational structure and maturity. We make no material changes to FY22 or FY23 estimates, and introduce estimates for FY24. |
Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement.
About Progressive:
Progressive helps you make informed investment decisions. FCA authorised and regulated, and with a 15-strong team of highly experienced analysts, we provide freely available institutional grade equity research and access to company management teams across every sector of the market.
Broad coverage
| Analyst calibre
| |||
across 12 sectors |
|
|
| |
|
|
|
|
|
Business Services | Oil & Gas | 15 | with average | 20 |
Financials | Property | experience of | ||
Healthcare | Retail |
| ||
Industrials | Technology | 30+ |
| techMARK |
Investment Trusts | Telecoms | industry based | Extel | |
Mining | Utilities | awards | StarMine | |
For further information please contact:
Keith Hodgskiss
+44 (0) 20 7781 5300
khodgskiss@progressive-research.com
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.